Network Point-of-Care Glucose Testing Market Opportunities and Challenges

The global Network Point-Of-Care Glucose Testing Market size is expected to reach USD 1.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.9% from 2021 to 2028. Some of the key industry participants are F. Hoffmann-La Roche Ltd., Abbott and Nova Biomedical. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.

Expanding patient base in Asia Pacific and the Middle East and the high demand for advanced diabetes management systems are creating significant growth opportunities in these regions. These regions also include some of the highly preferred destinations for medical tourism. Increasing demand for world-class healthcare services and rising adoption of advanced technology are some of the factors boosting the market growth in these regions.

Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.

Request a free sample copy or view report summary: Network Point-of-Care Glucose Testing Market Report

Network Point-of-Care Glucose Testing Market Report Highlights

Network point-of-care devices were in high demand during the first and second wave of COVID-19 owing to their advantage of remote patient monitoring

Based on product, the Accu-Chek Inform II segment held the largest revenue share in 2020 and is expected to expand at a lucrative growth rate during the forecast period

North America held the largest revenue share in 2020 and is predicted to maintain its lead over the forecast period owing to the factors such as the presence of major players and high adoption rate

Germany Pet Insurance Market Size, Share, Analysis and Forecast to 2028

The Germany Pet Insurance Market size is anticipated to reach USD 1.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.1% from 2021 to 2028. Petplan, Barmenia Versicherungen aG, ELEMENT Insurance AG, Coya Ltd. are some of the key industry participants. The growth is attributable to the increasing prevalence of acute and chronic pet health diseases, the humanization of pets, and supportive government regulations. For example, liability insurance is compulsory for certain dangerous dog breeds in states including Saarland, Bremen, Hessen, Nordrhein-Westfalen, and Baden-Wurttemberg.

The COVID-19 outbreak catalyzed the market with a surge in pet adoption and pet health concerns. Wertgarantie Group, the parent company of Agila, reported an exponential rise in the purchase of dogs and cats in Germany in 2020, amid the COVID-19 pandemic. This positively affected the company’s pet health insurance business with about 340,000 new contracts. However, this number contrasted the 475,000 veterinary bills processed during the period for the benefit of customers. As pet owners are becoming increasingly concerned about their pet’s health and wellbeing, the demand for pet insurance is expected to increase over time due to the high costs of treatment and surgery, awareness about pet health and diseases, and the humanization of pets.

Market players are involved in providing affordable and tailored insurance products to suit the needs and budget of pet parents. These include monthly or annual plans, plans based on coverage type, and sold through various sales channels. Barmenia Insurance, for instance, offers horse surgery insurance that provides coverage, from colic protection to premium surgery costs. The company’s dog and cat health insurance plans come in 4 variants, wherein all plans cover operations, including partial anesthesia or local anesthesia with no annual maximum.

Service additions to enhance product value is another unique selling point observed in the market. DFV Deutsche Familienversicherung AG, for example, partnered with FirstVet to offer veterinary telemedicine services to its animal health policyholders, thus establishing itself as an Insurtech company.

Related Press Release@ Germany Pet Insurance Market Report

Germany Pet Insurance Market Report Highlights

The dogs’ segment held the largest revenue share of 57.5% in 2020

The factors contributing to market growth include an increase in the number of pets, pet care expenditure, and chronic conditions such as joint disorders, fractures, and trauma, which require expensive treatments or surgical interventions

The health insurance segment dominated the market and accounted for a revenue share of 80.0% in 2020, owing to growing pet health concerns, and the need to curb expenditure

The agency segment dominated the market and accounted for a revenue share of over 56.0% in 2020

The broker segment, on the other hand, is expected to register notable growth in the coming years. SantéVet for instance provides a range of pet insurance products, wherein guarantees are taken out through an insurance brokerage company, Vetassur. SantéVet also partners with other brokers to reach more customers and gain market share

Cancer Diagnostics Market Growth, Trends and Analysis Report, 2026

The global Cancer Diagnostics Market size is expected to reach USD 249.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.0% during the forecast period. Continual introduction of innovative products, coupled with increasing need for early diagnosis of various diseases, is a prime factor driving the market. In addition, rapid growth of the healthcare and diagnostics sector can be attributed to penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering demand for these screening tests and imaging modalities used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early cancer diagnosis. In addition, cancer research organizations, along with public and private entities, are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease much before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility to these tests and products. For instance, Illumina, Inc. launched a new venture called GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than USD 100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests. 

Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/cancer-diagnostics-market

Further key findings from the report suggest:

Rapid     adoption of technology and escalating need for early diagnosis is     augmenting the growth of imaging systems. Thus, the segment is expected to     exhibit the fastest CAGR at 8.0% during the forecast period

The breast     cancer segment accounted for the largest share based on application due to     high incidence rate of breast cancer triggering the need for its early     diagnosis

In 2018,     North America dominated the global space with the largest revenue share of     42.0%. Focused research efforts in oncology for development of early tumor     detection tools, coupled with grants from government healthcare agencies,     are contributing to a strong medical ecosystem to fight cancer in this     region

Asia Pacific     is expected to emerge as the fastest growing region during the forecast     period. Favorable regulatory framework and growing patient pool in India,     China, and Japan due to support in diagnostic process at comparatively     lower prices are some of the factors boosting the market growth in this     region

Major     players competing in this market include GE Healthcare; Abbott;     Hoffmann-La Roche Ltd.; and Siemens Healthcare GmbH. Other prominent     players include but are not limited to Becton Dickinson & Company;     Illumina, Inc.; Koninklijke Philips N.V.; and Hologic, Inc.

About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/

Capillary Blood Collection Devices Market Trends and Analysis Report, 2025

The global Capillary Blood Collection Devices Market size is expected to reach USD 1.75 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.4% during the forecast period. Increasing incidence of chronic, infectious and autoimmune diseases are some of the major factors propelling market growth owing to rising number of blood tests globally. Capillary blood draw technique has been most widely used for glucose and hemoglobin testing in clinics and hospitals. Ease of usage and minimally invasive nature also makes it ideal for home care diagnosis and testing, thereby boosting the market’s growth potential.The use of this technique in conjugation with PoC diagnostics has become the chosen mode of testing in remote and ambulatory health settings.

Blood gas detection, leukocyte & metabolite count, biomarker, nucleic acid, blood glucose, ferritin, lactate, effect of vitamin K-antagonist, and heavy metal ions analysis is commonly done using these samples. Thus, with rising adoption of rapid PoC diagnostics, usage of these devices is anticipated to increase in the near future.

Chronic diseases are a global healthcare problem with over half of the adult population in the U.S. suffering from chronic diseases, which contribute to over 75% of the total healthcare cost in the nation. Thus, rising number of infectious and chronic diseases creates a huge demand for diagnostic testing, thereby propelling growth of these collection devices.

Capillary blood draw technique is most often used in case of pediatric patients as it is difficult to draw venous and arterial blood from infants. Capillary blood draw is preferred in many ICU settings as patients lose large amount of blood during surgeries. Other blood drawing techniques are more invasive and might result in delays in the healing process or pose a risk of contamination. Ease of usage and effectiveness is another factor facilitating the use of these devices for home care diagnosis and testing, typically in case of diabetics.

Browse Details of Report @   https://www.grandviewresearch.com/industry-analysis/capillary-blood-collection-devices-market

Further Key Findings From the Report Suggest:

Plastic     devices held the largest market share in 2017 owing to their lightweight,     cost-effective, and biocompatible nature coupled with extensive usage in     medical devices

Durability,     non-porous nature, and impermeability are boosting the demand for glass devices

Plastic and     glass based collection devices are anticipated to dominate the market     throughout the forecast horizon during the forecast period due to their     extensive use in the manufacture of medical devices and other related     products.

North     America will lead the market throughout the forecast period owing to     existence of large number of major market players and high incidence of     chronic and infectious diseases

The Asia     Pacific market is expected to rise at the highest CAGR during the same     period. High population along with rising incidence of chronic diseases     such as cancer and diabetes are the major factors contributing to the     growth of the regional market

Some of the     major players are Becton, Dickinson and Company; NIPRO Europe Corporation;     Sarstedt AG & Co; Thermo Fisher Scientific Inc.; Terumo Medical     Corporation; B Braun Melsungen AG; Kabe Labortechnik GmbH; Greiner Bio One     International GmbH; Cardinal Health; and Owen Mumford Ltd.

Emerging Opportunities and Current Trends for Virus Filtration Market

The global Virus Filtration Market size is expected to reach USD 7.0 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 12.7% during the forecast period. Increasing demand for biological products such as vaccines, therapeutic proteins, blood and blood products, cellular and gene therapy, tissue, and stem cell products is a major factor driving the growth. Biopharmaceuticals are mainly derived from human, animal, and plants and therefore require a scrutinized virus filtration procedure to avoid virus contamination in the production. Therefore, the necessity of this procedure during the production of biologics is expected to boost the market growth.

Many leading biopharmaceuticals and biotechnology manufacturers are involved in R&D to develop innovative biological products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in R&D, which was around 8% more than the R&D investment in 2015. This investment was mainly made to boost innovation and productivity in R&D to accomplish a sustainable pipeline of vaccines and differentiated therapies with lucrative commercial opportunities. Virus filtration is an important step in biologics development, thus, increasing R&D on biologics is expected to drive the product demand.

To request a sample copy or view summary of this report, click the link below:  https://www.grandviewresearch.com/industry-analysis/virus-filtration-market

Further key findings from the report suggest:

Consumables     was the largest revenue generating segment in 2018 owing to the increased     usage of consumables including reagents, kits, and membranes in biologics     downstream processing

Chromatography     technology segment is projected to expand at the fastest CAGR during the     forecast period, owing to advancements such as disposable or single-use     membranes that eliminate the risk of a potential virus contaminant

Biologicals     segment held the largest market share in 2018 and is projected to maintain     its dominance during the forecast period due to rising prevalence of     chronic diseases such as cancer, blood disorders, and diabetes

The     biotechnology and biopharmaceutical companies segment is projected to     expand at the fastest CAGR over the forecast period owing to increasing     investment in R&D and production of biologics

North     America led the virus filtration market in 2018 primarily due to the     presence of several leading biotechnology companies and increased R&D     activities

Asia Pacific     is estimated to expand at the highest CAGR during the forecast period.     Growing presence of CROs in countries including China and India due to the     presence of a large genome pool, less stringent regulations, and     availability of economical labor force is contributing to the regional     growth

Some of the     major players are Merck KGaA; Sartorius; Danaher; Thermo Fisher     Scientific, Inc.; Charles River Laboratories International, Inc.; GE     Healthcare; Asahi Kasei Medical Co., Ltd.; WuXi PharmaTech (Cayman) Inc.;     Lonza; and Clean Cells

Assisted Walking Device Market - Top Players, Outlook, Overview, Revenue Report

The global Assisted Walking Device Market is expected to reach over USD 2.0 billion by 2024 according to a new report by Grand View Research, Inc. The high market growth is anticipated onaccount of the steep rise in the geriatric population, high prevalence of chronic conditions, such as arthritis, Parkinson’s disease, conversion disorder, tendonitis, and the surging demand for rehabilitation equipment succeeding surgeries. 

Furthermore, apart from the initiatives commenced by the government and private institutions to encourage the use of these assistive walking aids to mobilize the physically-challenged, the technology-oriented innovationsare transforming the current assisted devices,which are expected toserve as catalystsfor the market growthover the forecast period. 

According to the estimates published by the WHO, the elderly population will rise from 900 million to 2.0 billion between 2015 and 2050.The demand for the walking devices is rising amongst thegeriatric population due mainlyto benefits, such as the provision of support, balance, and the subsequent ability to live independently. Moreover, the demand for the rehabilitation equipment is rising as a consequence of thesignificant role they play in bettering the lives of the physically-challenged. 

With the aging population on the rise, the global incidences of arthritis are also escalating in accordance. The estimate stated by the centers of disease control and prevention indicatesthat by 2040, 78 million people will be suffering from arthritis in the U.S.There are over 232 million surgeries performed per year, whichreflects the high demand for the assistive walking devices as a part of the post-surgery rehabilitation programs.

The key players are actively participating in the development of novel walking devices that will create a considerable impact on the quality and durability of the devices thereby influencing market growth.The government organizations and private institutions implement various laws and policies for theassisted devices commercially available to the physicallydisabled people in order to increase their accessibility. Varied government-led programs are specifically directed toward financially assisting individuals in purchasing mobility aids in several countries, such as India, Canada, and Australia.  

To request a sample copy or view summary of this report, click the link below:  http://www.grandviewresearch.com/industry-analysis/assisted-walking-device-market

Further key findings from the study suggest:

In 2015,     walkers accounted for the highest revenue share of 31.65%. The advantages     related to the use of walkers over other walking devices, which include     the improved ability to walk independently and safely, decreased pain and     discomfort while walking, and the provision of wider support as compared     to in other walking devices, and the high weight bearing capacity serve as     major reasons resulting in the sizeable revenue share.

The demand     is further accentuated due to the incorporation of these walkers in     rehabilitation programs that aim to enable physical activityamongst the     disabled, rebuilding of muscular strength, and to help attain optimal     mobility of muscles.

The crutches     segment is expected to emerge as the fastest growing segment with a CAGR     of 10.3% over the forecast period.This rapid growth pace is a result of     the high global demand for the crutches as supportive walking devices and     as equipment employed to provide rehabilitative care.The crutches minimize     the weight-bearing effect on the disabled leg and help improve the balance     and stability of the individual while walking.

In 2015,     North America dominated the Assisted Walking Device Market with a revenue     share of 39.58% owing to the hike in thegeriatric population, presence of     well-developed social and healthcare sectors, technological advancements     forwarded by the leadingplayers in this region, and various initiatives     commencedby the government and private organizations offering varied     supportive servicesfor the benefit of the physically disabled people.

The Asia     Pacific region is anticipated to grow at the maximum CAGR of over 10.7%     from the year 2016 to 2024.Increasing public and private healthcare     expenditure and the rising disposable incomes of the population are the key     factors supporting the growth of the Assisted Walking Device Market in     this region over the forecast period.

The market     dynamics indicate the presence of strong competition amongst the key     players, such as Carex Health Brands, Inc., Invacare Corporation, Drive     medical design and manufacturing, Inc., Sunrise Medical Laboratories,     Inc., Electric mobility Euro Ltd., Pride Mobility Products Corporation,     Briggs Healthcare Corporation, Graham-Field Health Products, Inc., Nova     medical products, and Patterson Medical Holdings, Inc.

Digital Patient Monitoring Device Market 2016: Industry Analysis & Outlook to 2026

The global Digital Patient Monitoring Devices Market size is expected to reach USD 272.6 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 27.9% during the forecast period. Rising prevalence of chronic conditions such as diabetes and hypertension is anticipated to drive the demand for real time patient monitoring for the management of these disorders. Digital monitoring platforms help in continuous patient monitoring, along with providing remote access to patient data and further reducing the clinical decision time.

Availability of mobile and telehealth applications for users is growing at a rapid rate, especially healthcare apps that assist consumers in self-management of disease, wellness, and chronic conditions. The increased patient role and importance in staying updated and informed about their own healthcare decisions, is contributing to the rise in adoption of digitized patient monitoring devices.

The mHealth segment is expected to expand significantly due to the high acceptance of products such as smart watches, smart bands, and clips. In May 2019, the Scripps Research Translational Institute expanded its mHealth study aimed at enhancing care management for pregnant women by launching POWERMOM, a digital health platform that combines an mHealth app and patient generated data from wearables to offer a better understanding in all stages of pregnancy.

Key players of digital patient monitoring device market are undertaking various strategic initiatives to sustain the competition. These initiatives include collaborations, mergers, acquisitions, and new product launches. For instance, in November 2015, Vital Connect signed an agreement with Omron Healthcare Co. to distribute HealthPatch MD in Japan. This agreement helped the company increase its geographical presence as well as market penetration.

To request a sample copy or view summary of this report, click the link below:  https://www.grandviewresearch.com/industry-analysis/digital-patient-monitoring-devices-market

Further key findings from the report suggest:

In 2018,     wearable technology held majority of share in the technology segment,     followed by mHealth technology. Physicians are increasingly recommending     the usage of mHealth apps to their patients, driving the adoption of     mHealth apps

Diagnostic     devices led the product segment due to the rise in consumer awareness     along with acceptance of digital patient monitoring utilities among     caregivers

North     America led the digital patient monitoring device market in 2018 in terms     of revenue share pertaining to the presence of major market players in the     region

Asia Pacific     is expected to witness significant growth over the forecast period,     attributed to rapid economic development coupled with untapped demand from     huge population

Key market     players include Omron Corporation; AT&T, Inc.; Philips Healthcare;     Airstrip Technologies; Athenahealth, Inc.; St. Jude Medical; Welch Allyn;     Medtronic Plc; GE Healthcare; Fitbit, Inc.; Garmin; Vital Connect; ResMed;     and Zephyr Technology Corporation

Global Intracranial Pressure (ICP) Monitoring Market Worth $1.9 Billion By 2025

The global Intracranial Pressure Monitoring Devices Market is expected to reach USD 1.9 billion 2025, according to a new report by Grand View Research, Inc. Increasing neurological disorders and growing awareness regarding various treatment options available is spurring the growth of these devices on a global level. In addition, constant rise in patient numbers suffering from severe brain diseases that lead to high intracranial pressure is expected drive the growth of the market during the forecast period.

Mainly, high disease prevalence and increased research funding together are expected to positively affect the growth of the ICP monitoring devices market. However, high cost of the devices and lack of skilled professionals in the developing regions are some of the prime factors hindering growth of the market.

 To request a sample copy or view summary of this report, click the link below:  http://www.grandviewresearch.com/industry-analysis/intracranial-pressure-icp-monitoring-devices-market

Further Key Findings from the Study Suggest:

The market     study suggests that invasive technique dominated the overall market in     2015 due to accurate and continuous measurements of intracranial pressure     with intermittent drainage (hourly), unless clinically indicated

Among the     invasive techniques, External Ventricular Drainage (EVD) occupied the     largest share as it is considered as the gold standard for monitoring of     intracranial pressure.

EVD also     enables drainage of cerebrospinal fluid and administration of medicine     intrathecally, which is positively impacting the growth of this segment

North     America dominated the vertical with the largest revenue share in 2015.     Presence of a large target population suffering from traumatic brain     injury and high adoption rate of advanced treatment options are some of     the factors driving the growth of the intracranial pressure monitoring     devices in North America.

Asia Pacific     is anticipated to show significant growth during the forecast period.     Growth of the region is primarily attributable to increasing government     initiatives, growing awareness regarding neurological disorders, and the     availability of diagnostic procedures for their treatment.

Some of the     top companies operating in this market are Medtronic plc; Codman &     Shurtleff, Inc.; RAUMEDIC AG; Vittamed; Sophysa Ltd.; Orsan Medical     Technologies; Integra LifeSciences Holdings Corporation; and Spiegelberg     GmbH & Co. KG.

Portable X-Ray and CT Scan Devices Market Analysis By Product and By Technology

The global Portable CT Scan And X-Ray Device Market are expected to reach USD 8.41 billion by 2020. Increasing demand for home healthcare, bedside imaging, and growing use of CT scan to assess the accuracy of medical implants, post interventional medical procedures and anatomical confirmation are key factors driving industry growth.

Rising prevalence of diseases such as cancer, cardiovascular, dental and orthopedic disorder will also augment the growth of the market. Also, an increase in the number of medical implants surgeries owing to unhealthy lifestyle as well as growing base of geriatric population is expected to bolster demand.

The portable X-ray device were dominated by mobile X-ray machines on account of rising demand for core diagnostic and bedside imaging. These device also eliminate the requirement for multiple radiology departments in a healthcare institution, thus promoting industry growth. The handheld X-Ray device market is poised to experience substantial growth over the forecast period owing to high maneuverability and the introduction of products such as NOMAD Pro.

Portable CT scan device market was dominated by the medium slice scanners due to high image resolution capabilities and high usage rates. Medium slice scanner accounted for over 58% of portable CT scan by technology in 2013. Digital radiography, owing to increasing demand for manufacturing filmless X-ray and PACS based radiology device, is identified as the fastest growing technology among the overall market.

Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/portable-x-ray-and-ct-scan-device-industry

North America is expected to dominate the market demand for these device over the forecast period owing to high expenditure on healthcare, reimbursement framework and sophisticated healthcare infrastructure. However, Asia Pacific is expected to witness the fastest growth, growing at a CAGR of more than 9% owing to improving healthcare infrastructure particularly in emerging economies such as China and India. In addition, the advent of technologically advanced and economical products catering to cost sensitive clientele in the region will fuel the growth of the market.

Supportive government regulations in Asia Pacific promoting manufacturing in the region is expected to drive demand for portable medical machines. Furthermore, low labor cost coupled with abundant tier I companies is projected to propel portable medical machines manufacturing in the region. As a result, product cost is likely to decrease over the forecast period owing to technological advancements which in turn is expected to drive demand, particularly in the emerging economies.

Philips Healthcare was the dominant player in the portable X-ray machines market with a market share of over 17% in 2013. Philips possessed an extensive product portfolio ranging from stationary X-ray systems to digital and portable X-ray systems. Some of the other key players in the industry are Hitachi Medical Systems and Varian Medical Systems, GE Healthcare, and Siemens Healthcare.

Population Health Management Market Worth $101.0 Billion By 2025

The global Population Health Management Market size is expected to reach USD 101.0 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 20.7% during the forecast period. The need for population health services that combine multiple functionalities is increasing, due to the complex nature of care delivery and payment models. PHM solutions can process clinical, financial, and operational data for the improvement of efficiency and patient care. The convenience offered by value-based payment models instead of Fee-for-Service (FFS) is responsible for increased adoption of these solutions by the Accountable Care Organizations (ACOs).

ACOs, consist of hospitals, clinics, doctors, and other caregivers, collaborate with payers for the delivery of high-quality patient care. Private and public insurance providers have introduced various disease management programs, to assist in the treatment of chronic illnesses. These multidisciplinary efforts are expected to result in effective treatment outcomes and are likely to suggest best suitable courses of action that need to be undertaken. Successful large-scale trials in U.S. have enabled significant advancements in disease management programs.

The market has a healthy mix of vendors offering PHM along with other healthcare IT solutions. Acquisitions and partnerships are the major strategies adopted by the companies operating in the population health management market. For instance, in 2018 Allscripts announced completion of acquisition of the HealthGrid Holding Company, a developer of enterprise patient engagement solution. The acquisition signifies expansion of the Allscripts FollowMyHealth platform that provides patient engagement solutions focused on connecting consumers with providers. 

Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/population-health-management-phm-market

Further key findings from the report suggest:

Based     on the products, the services segment held majority of the market share in     2018, as healthcare providers prefer in-house maintenance services

In     2018, healthcare provider held the largest market share of the end-use     segment. The providers can focus effectively on patient-centric care and     reducing overall costs

North     America was the largest regional market in 2018 and is likely to retain     its position over the forecast period, as the providers, payers,     providers-payers, and accountable care organizations promote the use of     PHM services

Asia     Pacific is expected to witness the fastest growth in the forthcoming years     due to rising healthcare expenditure and improving healthcare     infrastructure

Allscripts,     McKesson Corporation, and Cerner Corporation among others are some of the     key players operating in the Population Health Management (PHM) market.     Business partnerships and acquisitions are some of the key strategic     initiatives undertaken by these companies to strengthen their market     presence.

About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/

Women’s Health Therapeutics Market Trends,Segmentation and Future Scope

The global Women’s Health Therapeutics Market size is expected to reach USD 210.9 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.8% over the forecast period. Entry of effective drugs, a rise in awareness about early diagnosis and treatment, along with prevalence of chronic diseases are among the key factors likely to drive the market during the forecast period.

The women’s health therapeutics market is expected to witness high growth in the forthcoming years due to increasing investment by key market players to fulfill demand in areas of infection, cancer, and pregnancy-related complications. In October 2016, Prelude Fertility, Inc. received USD 200 million from the Reproductive Biology Associates (RBA) and My Egg Bank North America (MEB) that focuses on providing fertility services and treatment to people with delayed childbirth. Juneau Biosciences, LLC has deployed USD 35 million until 2017 towards development of molecular diagnostics and therapeutics for endometriosis (uterus) conditions.

In January 2018, Melinta Therapeutics, Inc. acquired The Medicines Company’s infectious diseases business. This acquisition would help to the former expand its portfolio by offering life-saving treatment options. In November 2017, Biocon launched KRABEVA, a biosimilar used for the treatment of metastatic colorectal, cervical, ovarian, and brain cancer. Increasing investments by top market players are anticipated to propel the global market over the forecast period.

There is significant unmet need associated with treatment options for female sexual dysfunction. Currently, there are no Food and Drug Administration (FDA)-approved drugs for the treatment of female sexual dysfunction and many promising molecules are in late stage of development phase. Some of these molecules include LibiGel by BioSante Pharmaceuticals and Femprox by Apricus Bio, currently in Phase III and Phase II of clinical trials respectively in U.S.

Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/womens-health-therapeutics-market

Further key findings from the report suggest:

By     type, infection accounted for the largest market share in 2017 and is     expected to maintain its dominance during the forecast period due to     rising drug approvals, availability of diagnostic tests and treatments,     and high incidence of infectious diseases

Ovarian     cancer is anticipated to be the fastest-growing sub-segment of oncology     during the forecast period due to high prevalence of ovarian cancer and     approval of new and improved drugs

North     America is expected to maintain its dominance in the coming years due to     high awareness about women’s health, increase in number of advanced     diagnostic and treatment methods, mergers and acquisitions by market     players, and rise in infections and cancer cases

Asia     Pacific is likely to witness significant growth over the next decade due     to improving healthcare facilities, increase in commercialization and     approval of products, and investment by market players

Some     of the key players in women’s health therapeutics market are Bayer AG,     Merck & Co., Pfizer, Teva Pharmaceutical Industries Ltd, AstraZeneca,     Bristol-Myers Squibb (BMS) Company, Eli Lilly and Company, Novartis AG,     GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Mylan N.V., Sun     Pharmaceutical Industries Ltd, and Sanofi.

About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/

Electron Microscope Market Demand, Growth, Trends and Opportunities

The global Electron Microscope Market size is expected to reach USD 5.7 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 7.4% over the forecast period. Rising investment in research and increasing use of electron microscopes in industries such as semiconductors, life sciences, and materials research Industries is anticipated to boost the market growth. Developing countries offer new investment avenues to the global market giants. The developing infrastructure and increasing research investments are driving the demand for advanced medical devices in these countries.

Microscopes are used extensively in the field of semiconductors. In the field of life sciences, they can be used in clinical trials, toxicology, pathology, diagnosis of diseases, and various other sub disciplines. Microscopy can also be used for characterization of materials, to study their internal structures, and various other applications. They are used in forensics, food industry, healthcare, and chemical among other industries.

Few of the key players in the electron microscopes market are Nikon Metrology Inc.; Thermo Fisher Scientific.; ZEISS, International; JEOL Ltd.; Angstrom Advanced Inc.; Hirox Europe Ltd.; and Hitachi High-Technologies Europe GmbH. Regional and service portfolio expansions and mergers and acquisitions are the key strategic undertakings adopted by these players. For instance, in June 2018, Thermo Fischer Scientific acquired electron microscope software console from Roper technologies.

Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/electron-microscopes-market

Further key findings from the study suggest:

The global     electron microscopes market was valued at USD 3.2 billion in 2017 and is     expected to grow lucratively over the forecast period

Scanning     electron microscope segment is anticipated to expand at the fastest CAGR     over the forecast period

Life     sciences segment captured the largest market share in 2017

Nanotechnology     is expected to witness the fastest CAGR during the forecast period owing     to increasing investments

Asia Pacific     is expected to exhibit high growth over the forecast period owing to     rising investments from global market players.

About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/

Mouth Ulcers Treatment Market Demand, Growth, Trends and Opportunities

The global Mouth Ulcers Treatment Market size is projected to reach USD 1.32 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 3.8% during the forecast period. Increasing geriatric population and rising awareness towards oral hygiene are among the key trends stimulating market growth.

Growing global geriatric population is poised to trigger the number of cases of mouth ulcers. As per the findings of the United Nations Organization (UNO), population base of age 60 years or older across the globe was 962.0 million in 2017, which was more than twice as large as in 1980, when the population was 382.0 million. With upswing in the demand for denture fittings in this population, rise in the incidences of improper fittings and deficiency of vitamin B & folic acid is anticipated. Such incidents can lead to mouth ulcers.

Newly fitted dentures takes some time to adjust. During the procedure, inner area of the mouth remains moist for a certain period. Such conditions favor fungal infection leading to ulcer. Older population often suffer from such conditions, due to which they are prone to oral problems. In addition, deficiency of vitamins is a common phenomenon observed among geriatric population, which also increases the probability of suffering from mouth ulcer.

Rising awareness regarding oral hygiene in developing countries is also estimated to drive the market over the forecast period. Campaigns on oral hygiene in rural areas of developing countries are working in favor of the market. For instance, every year, Colgate-Palmolive Company conducts an oral health month in rural areas of India in order to impart awareness regarding oral hygiene. Such initiatives are expected to encourage people to take up necessary treatments. Furthermore, rise in tobacco usage in countries such as U.K. and Mexico is projected to boost the rate of mouth ulcers, thereby benefitting the growth of the market.

Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/mouth-ulcers-treatment-market

Further key findings from the report suggest:

Analgesics     and Corticosteroids are poised to exhibit the highest CAGR during the     forecast period. These are the most prescribed drugs by doctors and are     easily available

By 2026,     Asia Pacific is likely to dominate the mouth ulcer treatment market with a     share of around 63.0%. Increasing awareness pertaining to oral hygiene and     treatment and rising prevalence of aphthous ulcers are likely to     supplement the growth of the market

Some of the     key companies present in the market are Blistix Inc., Church & Dwight     Co., Inc., 3M, Colgate-Palmolive Company, Pfizer, Bristol-Myers Squibb     (BMS), and others are expected to dominate the market over the forecast     period.

About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/

Bench-top Dental Autoclaves Market Demand, Growth, Trends and Opportunities

Global Bench-Top Dental Autoclaves Market is expected to reach USD 64.35 million by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of dental disorder and rising patient awareness levels pertaining to sterilization are some major growth impacting drivers of this market. With remote and mobile healthcare access becoming the need of the hour, bench-top dental autoclaves are expected to witness a surge in demand over the next six years. In addition, growing number of initiatives aimed at curbing hospital acquired healthcare infections related expenditure via sterilization is expected to enhance market demand during the forecast period.

Automatic bench-top autoclaves are the most lucrative segment of this market and are expected to grow at a CAGR of over 6.5% during the forecast period. Growing demand for automatic bench-top dental autoclaves, on account of its ability to render error free and faster results is one of the major factors accounting for the segment’s rapid growth. Additionally, North American and European countries pursuing device automation, is expected to positively impact market growth over the next six years.

Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/bench-top-dental-autoclave-market

Further key findings from the study suggest:

Pre and post     vacuum bench-top autoclaves were the leading product segment in 2013. High     market penetration rates and cost effectiveness associated with these     products are some factors accounting for its large share.

North     America was the most revenue generating region, accounting for over 40.0%     of the market in 2013. Major factors attributing to its large share     include the presence of relatively higher healthcare expenditure and     patient awareness levels and large dental procedure volumes. Extensive     presence of government initiatives monitoring and implementing medical     device sterilization in the region is also expected to drive market     growth.

Asia Pacific     is expected to present this market with lucrative future growth     opportunities. Large prevalence of dental diseases and rising patient     awareness levels coupled with improving healthcare framework in the     emerging markets of India and China are expected to result in a surge in     product demand during the forecast period. Increasing number of dental     procedures and a heightened need for safe medical practices owing to     quickly rising demand for dental tourism in these markets are also     expected improve device usage rates.

Some key     players of the bench-top dental autoclaves market include Tuttnauer, FONA     Dental, W&H Dentalwerk International, Melag, Midmark and Antonio     Matachana. 

Development     of technologically advanced and cost effective products via rigorous     R&D investments is a key growth strategy adopted by these players.     These companies also enter into strategic alliances with dentists and     focus on enhancing brand awareness through community activities.

About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/